Abridge vs Nabla
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Abridge
Ambient AI that drafts clinical notes and codes from the patient conve...
Visit
|
Nabla
Ambient AI scribe that turns patient visits into clinical notes.
Visit
|
|
|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 8.2 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Enterprise | Custom |
| Free tier | — | Free trial available with core documentation features and limited usage |
| Paid from | Quoted on request (health-system contracts, no published price) | Not published — free trial via app.nabla.com; practices and enterprises by quote |
| Has API | ✗ | ✓ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✗ |
| Users | 200+ health systems; ~50-80M clinical conversations/year | 85,000+ clinicians across 150+ health organisations (mid-2025) |
| Founded | 2018 | 2018 |
| Maker | Dr. Shivdev Rao (CEO), Sandeep Konam (CTO), Florian Metze (CSO, departed 2019) | Nabla Technologies |
| Verdict | Abridge is one of the most widely deployed ambient scribes in US healthcare, with more than 300 health systems by its own count, KLAS's top Ambient AI ranking in the Revenue Cycle category two years running, and a platfo... |
Nabla has the strongest head-to-head evidence in ambient scribing: a single-centre randomised trial at UCLA, published in NEJM AI, found Nabla users cut time in notes by a statistically significant 9.5% where Microsoft's... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.